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Abstract
Background—Although seasonal variation in tuberculosis incidence has been described in 
several recent studies, the mechanism underlying this seasonality remains unknown. Seasonality of 
tuberculosis disease may indicate the presence of season-specific risk factors that could potentially 
be controlled if they were better understood. We conducted this study to determine whether 
tuberculosis is seasonal in the United States and to describe patterns of seasonality in specific 
populations.
Methods—We performed a time series decomposition analysis of tuberculosis cases reported to 
the Centers for Disease Control and Prevention from 1993 through 2008. Seasonal amplitude of 
tuberculosis disease (the difference between the months with the highest and lowest mean case 
counts), was calculated for the population as a whole and for populations with select demographic, 
clinical, and epidemiologic characteristics.
Results—A total of 243 432 laboratory-confirmed tuberculosis cases were reported over a period 
of 16 years. A mean of 21.4% more cases were diagnosed in March, the peak month, compared 
with November, the trough month. The magnitude of seasonality did not vary with latitude. The 
greatest seasonal amplitude was found among children aged <5 years and in cases associated with 
disease clusters.
Conclusions—Tuberculosis is a seasonal disease in the United States, with a peak in spring and 
trough in late fall. The latitude independence of seasonality suggests that reduced winter sunlight 
exposure may not be a strong contributor to tuberculosis risk. Increased seasonality among young 
children and clustered cases suggests that disease that is the result of recent transmission is more 
influenced by season than disease resulting from activation of latent infection.
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Tuberculosis is a leading cause of death globally. Although one-third of the global 
population is estimated to be infected with Mycobacterium tuberculosis bacillus, only a 
minority of people with tuberculosis infection will develop tuberculosis disease [1]. 
Tuberculosis disease occurs through 1 of 2 pathways. The first is through recent infection 
that progresses to disease within a short period of time, reflecting ongoing transmission of 
tuberculosis. Alternatively, after infecting a person, M. tuberculosis may enter a state of 
prolonged latency. Persons with latent tuberculosis are neither ill nor contagious, but a small 
proportion of them will develop active tuberculosis disease later in life. Latent tuberculosis 
thus represents infection that was acquired remotely, often years earlier, that can later 
activate to tuberculosis disease. It is estimated that approximately three-quarters of 
tuberculosis cases in the United States are attributable to activation of latent infection and 
one-quarter to recent transmission [2].
Studies in the preantibiotic era [3] and more recent analyses in the United Kingdom [4], 
Spain [5], Hong Kong [6], India [7], and South Africa [8] have found a seasonality of the 
incidence of tuberculosis that is highest in late spring or early summer. The mechanisms 
underlying seasonal variation in tuberculosis disease are unknown. One dominant hypothesis 
in the literature suggests that spring surges in tuberculosis result from increased activation of 
latent tuberculosis due to late winter nadirs in vitamin D [9], an immune regulator 
synthesized in sun-exposed skin that enhances cellular immunity against M. tuberculosis in 
vitro [10]. An alternative hypothesis proposes that springtime peaks in tuberculosis 
diagnosis are due to increased transmission of tuberculosis rather than an increase in 
activation of latent disease, perhaps due to wintertime indoor crowding [7, 8].
Understanding the determinants of seasonality can shed light on pathogenesis of disease, 
identify potentially modifiable risk factors, and suggest new therapeutics. The aims of this 
study were to determine if seasonality of tuberculosis exists in the United States and to 
characterize patterns of seasonal variation in tuberculosis diagnoses among specific 
populations.
Methods
We analyzed laboratory-confirmed tuberculosis cases from all 50 states and the District of 
Columbia reported to the Centers for Disease Control and Prevention (CDC) National 
Tuberculosis Surveillance System who started tuberculosis treatment between 1 January 
1993 and 30 November 2008. Laboratory confirmation was based on positive M. 
tuberculosis culture or positive acid-fast bacilli smear examination. Covariates examined 
were sex, age, race and ethnicity (self-designated), reporting state, site of disease, chest 
radiographic findings, human immunodeficiency virus (HIV) status, origin of birth (US-born 
or foreign-born), and years in the United States prior to tuberculosis diagnosis among 
foreign-born persons.
A case was defined as exclusively pulmonary if the only site of disease reported was 
pulmonary (ie, no additional site of disease was specified) and exclusively extrapulmonary if 
the reported site(s) of disease was not pulmonary. For analyses based on site of disease, any 
patient with both pulmonary and extrapulmonary tuberculosis was excluded. Patients with 
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abnormal chest radiographs were categorized radiologically as having cavitary or 
noncavitary disease by the reporting health department. US-born persons were defined as 
those either born in the United States (or its jurisdictions) or those born in a foreign country 
with at least 1 US citizen parent. Foreign-born persons were categorized into those who 
were diagnosed with tuberculosis within 1 year vs >1 year after entry into the United States. 
Time since entry into the United States was calculated by subtracting the month and year of 
US entry from the month and year the case was reported.
We categorized the 50 states and the District of Columbia into 5 latitude strata by intervals 
of 4° based on the midpoint latitude of each state and calculated seasonal amplitude for each 
stratum.
Tuberculosis clusters generally refer to a grouping of cases occurring within a certain 
geographic region and time frame that are potentially related through a single chain of 
disease transmission. For analysis of clustered cases, we utilized routinely collected data 
from the CDC National Tuberculosis Genotyping Service [11] linked to demographic and 
clinical data on reported tuberculosis cases in the National Tuberculosis Surveillance 
System. Cases with a treatment start date between 1 January 2005 and 30 November 2008 
with the same genotype (based on indistinguishable spoligotype and 12-locus mycobacterial 
interspersed repetitive units–variable number of tandem repeats results reported within 
statistically significant geospatial zones determined by a spatial scan statistic [12] using 
SaTScan version 9.1.0 [13] were defined as clustered cases.
Time Series Analysis
Monthly case counts were analyzed with SAS version 9.2 [14] using a time-series 
decomposition method (X-11) developed by the US Census Bureau to seasonally adjust 
census data [15, 16]. The seasonal component was isolated from overall trend and irregular 
factors (noise) through the multiplicative model, Xm = Tm × Sm × Im , where Xm is the 
observed number of persons starting tuberculosis treatment in month m, Tm is the trend 
component, Sm represents the seasonal factors, and Im is the random, or irregular, factors. 
Figure 1 demonstrates the seasonal decomposition of laboratory-confirmed tuberculosis 
cases in the United States from 1993 through 2008. This decomposition method uses an 
iterative procedure that passes through the series data 3 times. First, a preliminary estimate 
of the trend is obtained by averaging logarithm values in a 13-month moving window. This 
preliminary trend is removed from the original series, leaving the combined seasonal and 
irregular components. A moving average applied to this series, with adjustment to reduce the 
influence of extreme values, gives a preliminary estimate of the separate seasonal and 
irregular components. This seasonal component is removed from the original series, giving 
an updated estimate of the combined trend and irregular components. The seasonal 
component is updated again, and then the trend, yielding the final result after 2 more 
iterations of this procedure.
A decomposition of monthly case counts was obtained for each population of interest. The 
presence of seasonality was assessed through the X-11 combined test of identifiable 
seasonality, which combines the stable and moving F statistics with the Kruskal-Wallis test. 
We calculated mean peak month, trough month, and annual seasonal amplitude with 95% 
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confidence intervals (CIs) for populations with identifiable seasonality. Confidence intervals 
were calculated using the Wald method based on the variance around the mean of the 16 
yearly amplitude measurements. Annual seasonal amplitude was calculated from isolated 
seasonal factors and was defined as the peak-to-trough difference between the months with 
the highest and the lowest case counts for that year. Annual seasonal amplitude is expressed 
as a proportion of mean case counts to facilitate comparison between groups.
Results
A total of 243 432 laboratory-confirmed tuberculosis cases were reported to the CDC during 
the study period, which ranged over 191 months (approximately 16 years). Figure 1A shows 
monthly case counts with the X-11 seasonal decomposition of the isolated trend (Figure 1B), 
seasonal (Figure 1C), and irregular (Figure 1D) factors. Examination of the raw data showed 
a consistent annual periodicity. There was a steadily decreasing trend over the 16-year 
period. Removal of the trend reveals the seasonal and irregular (random) factors of the time 
series. From the isolated seasonal factors we found that seasonal amplitude for the United 
States was 21.4%; that is, an annual mean of 21.4% more cases of tuberculosis were 
diagnosed in the peak month compared with the trough month. The month with the greatest 
number of cases fell between March and May in 15 of 16 years; the month with the least 
number of cases was November or December in all years. Analysis of the isolated seasonal 
component revealed that mean cases per month peaked in March, with a trough in 
November.
Table 1 illustrates the peak and trough months with amplitude of seasonal variation for 
populations of interest. We found no latitude gradient for the seasonality of tuberculosis in 
the United States. The midpoint latitudes for Hawaii, the southernmost state, and Alaska, the 
northernmost state, are 21.1° and 61.4°, respectively, a latitude range of 40.3°. Within the 48 
contiguous states, the midpoint latitudes of Florida and North Dakota are 27.8° and 47.5°, 
respectively, a range of 19.7°. We found that inhabitants of the 11 northernmost states, with 
midpoints above 44° latitude (Alaska, North Dakota, Washington, Montana, Minnesota, 
Maine, Oregon, South Dakota, Wisconsin, Idaho, and Vermont) exhibited a magnitude of 
seasonal variation in tuberculosis disease similar to that of inhabitants of the 9 southernmost 
states, located below 34° (South Carolina, Arizona, Georgia, Alabama, Mississippi, 
Louisiana, Texas, Florida, and Hawaii).
By contrast, the magnitude of seasonality was strongly associated with age. Among children 
<5 years, in whom disease likely represents recent transmission with early progression to 
disease, seasonal amplitude was 55.5%. The amplitude of seasonality declined progressively 
with increasing age to 19.4% among persons aged ≥65 years (Table 1). Cases associated 
with genotype disease clusters, in whom tuberculosis disease also likely represents recent 
disease transmission, exhibited a seasonal amplitude of 44.9%, more than twice the value for 
the overall population. Among nonclustered cases, seasonality was not detected.
Seasonal amplitude was 29.2% among persons of black race, compared with 17.8% for 
those of white race. Seasonal amplitudes of 23.8% and 26.9%, respectively, were observed 
for persons self-reporting as Asian or Hispanic. Seasonality analysis limited to those of 
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black race (Table 2) showed no association with latitude but showed a strong relationship 
with younger age, consistent with the patterns seen in the broader population. Data for 
clustered cases were too sparse for meaningful stratified analysis of seasonality by race. We 
found that 34% of tuberculosis isolates from persons of black race were part of a disease 
cluster compared with 19% among those of white race.
Seasonal variation was also higher among persons with cavitary disease (28.7%) and among 
persons with extrapulmonary disease (32.2%) compared with those with either non-cavitary 
(21.2%) or pulmonary disease (21.0%), respectively. There was no substantial difference in 
amplitude of seasonality by sex or by HIV status. Foreign-born persons diagnosed with 
tuberculosis within 1 year of entry into the United States exhibited decreased seasonal 
amplitude (17.6%) relative to both US-born persons (24.2%) and foreign-born persons 
diagnosed with tuberculosis >1 year after arrival to the United States (26.1%).
Discussion
Tuberculosis is a seasonal disease in the United States, with a peak in spring and trough in 
late fall. The seasonal pattern is similar to what has been found in non-US studies. We did 
not detect greater amplitude of seasonality at higher latitudes, suggesting that latitude-
dependent factors, including reduced winter sunlight and its potential effect on vitamin D 
levels, do not appear to contribute significantly to seasonality in the United States. Instead, 
we found the degree of seasonality is greater among clustered cases and children, groups in 
whom disease likely reflects recent transmission of tuberculosis. Our interpretation of this 
finding is that tuberculosis disease resulting from recent infection with early progression to 
disease appears to be more influenced by season than disease that results from activation of 
latent tuberculosis.
Recent Transmission Hypothesis
The amplitude of seasonality was nearly 4-fold higher among children aged <5 years who, 
as children, must have had relatively recent infection with M. tuberculosis compared with 
persons aged ≥65 years, who may have been infected decades earlier. Clustered cases are 
likely to be linked through recent transmission, as opposed to nonclustered cases, which 
more commonly represent genotypically unique isolates and activation of remote infection 
[17]. We found that there were 45% more clustered cases in the spring peak month than the 
fall trough month. No seasonal variation among nonclustered cases was detected.
The finding that seasonal amplitude is increased among persons of black race may be 
attributable to increased disease transmission in this population. An association between 
black race and tuberculosis disease clustering in the United States has been described [18, 
19]. We found persons of black race were nearly twice as likely to be associated with a 
disease cluster than those of white race (34% vs 19% of cases, respectively). The greatest 
amplitude of seasonality among populations we analyzed was for children of black race <14 
years, with 60% more cases in the spring peak month than the fall trough month.
For patients who develop tuberculosis disease after recent infection, as opposed to entering a 
state of prolonged latency, the windows between infection and symptom onset and between 
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symptom onset and diagnosis of tuberculosis are variable. The average period to tuberculosis 
diagnosis from symptom onset was 47 days in high-income countries in a recent meta-
analysis [20]. The antecedent window between infection and development of symptoms is 
not well described. Thus, March peaks may reflect a window of increased risk of 
transmission, or vulnerability to infection, that begins in winter, probably in November 
and/or December.
A peak in March and trough in November indicates a consistently steep upswing in cases, 
with a more gradual downswing (Figure 1C). The gradual downswing in tuberculosis 
diagnosis after the spring peak may reflect variations in time from infection to diagnosis 
following a common period of increased transmission in winter.
Authors of studies of seasonality of tuberculosis in India [7] and South Africa [8] suggest 
that increased tuberculosis disease transmission in winter may be due to increased indoor 
crowding in colder winter weather. However, we found that cases peaked in spring for all 
latitude strata in the United States. Seasonal patterns of indoor congregation are unlikely to 
be uniform throughout the United States. Thus, if seasonality of tuberculosis in the United 
States is due to increased transmission in winter, the mechanism may not be as simple as 
increased indoor crowding.
Vitamin D Hypothesis
It has been postulated that the role of vitamin D in tuberculosis seasonality is mediated 
through increased risk of activation of latent tuberculosis due to late winter nadirs in vitamin 
D levels. Latitude is closely associated with ultraviolet light exposure [21], and negligible 
cutaneous vitamin D synthesis occurs during winter months for people living north of 40° 
latitude [22]. Seasonal variation in vitamin D (25-hydroxyvitamin D) levels is more 
pronounced among those living north of 37° [23]. Vitamin D enhances cellular immunity 
against M. tuberculosis in vitro [10]. Wilkinson et al found an association between vitamin 
D deficiency and tuberculosis disease among Gujarati Asians living in West London [24]. In 
the United States and England, recent immigrants experience higher rates of tuberculosis 
disease than immigrants who are long-term residents [25]. Vitamin D deficiency associated 
with a move into a more northern latitude has been hypothesized to contribute to the 
increased incidence of tuberculosis disease seen among recent immigrants [9].
On the basis of these studies, investigators have suggested empiric vitamin D 
supplementation to prevent activation of latent tuberculosis among immigrants moving from 
equatorial to northern latitudes [9]. Our findings showing the latitude independence of 
seasonality and decreased seasonality among populations representing activation of latent 
tuberculosis, including recent arrivals to the United States, suggest that vitamin D 
supplementation may not prevent most cases among immigrants.
Darker skin pigmentation is independently associated with higher risk of vitamin D 
deficiency [26, 27]. Cases of tuberculosis among persons of black race exhibited a greater 
degree of seasonality relative to persons of white race; however, the amplitude of seasonality 
among persons of black race did not vary by latitude. Additionally, other studies conducted 
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in the United States show that persons of black race are more likely to be associated with 
tuberculosis genotype clusters, suggesting recent transmission [18, 19].
If vitamin D does play a role in tuberculosis seasonality, it may be through mechanisms not 
yet well understood. Although the utility of vitamin D in tuberculosis treatment remains 
uncertain, some trials have demonstrated success among patients with variants in the vitamin 
D receptor gene [28, 29]. Vitamin D receptor polymorphisms have also been associated with 
both increased risk of vitamin D deficiency and tuberculosis disease [30, 31]. It is possible 
that such individuals represent a subpopulation in whom seasonal variation in vitamin D 
levels may seasonally affect tuberculosis risk, although in the United States this is likely to 
be either uncommon or not related to latitude-dependent ultraviolet radiation exposure.
Alternative Hypotheses for Tuberculosis Seasonality
A wide variety of infectious diseases exhibit seasonality [32, 33]. Coinfection with other 
seasonal pathogens may affect vulnerability to tuberculosis disease. Viral respiratory 
infection may increase susceptibility to tuberculosis infection and/or progression to disease 
[34]. Influenza is strongly seasonal in the United States, with a winter peak in both northern 
and southern latitudes. The effect of respiratory viral pathogens on concomitant pulmonary 
infection is evidenced by the association between influenza and pneumococcal pneumonia 
[35]. Helminthic infections, chickenpox, and measles also increase risk of tuberculosis 
disease [36–38].
Seasonal changes in population susceptibility based on fluctuations of neuroendocrine 
function and immune response have been proposed to contribute to seasonality of infectious 
diseases [33]. Glucocorticoid and melatonin levels, which, like vitamin D, influence cellular 
immune response in vitro, vary seasonally [39]. The clinical manifestation of tuberculosis 
toward cavitary or extrapulmonary disease is strongly influenced by host immunologic 
capacity, and these forms of disease are more common among immunosuppressed patients 
[36]. Our finding of increased seasonality among these forms of tuberculosis may reflect 
relative seasonal immunosuppression in winter.
It has been suggested that spring surges in tuberculosis cases may be due to delay in 
diagnosis of wintertime disease [40]. In winter, cough and fever are common seasonal 
symptoms and are usually reflective of viral upper respiratory infection. Thus, missed 
diagnosis of tuberculosis early in its course may occur more frequently in winter. This could 
lead to both longer periods of infectivity and increased transmission during winter, as well as 
more cases of advanced disease detected in the spring. Although we found greater seasonal 
variation in cavitary disease, which generally represents more advanced disease than 
noncavitary disease [34, 36], March was the peak month for both forms of disease.
In conducting an ecologic study, we were unable to address the cause of seasonal variation 
in disease directly. However, because our study is based on a very large sample size accrued 
over an extended time frame and includes substantial information regarding patient-level 
characteristics, we were able to shed some light on the potential determinants of tuberculosis 
seasonality. We hope these findings help inform the direction of future research regarding 
factors related to tuberculosis transmission and progression to disease.
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In conclusion, tuberculosis is a seasonal disease in the United States, with a peak in spring 
and trough in late fall. The data suggest that in the United States, latitude-dependent factors, 
including reduced winter sunlight exposure and its potential effects on vitamin D levels, may 
not contribute significantly to seasonality. Increased seasonality among children and cases 
clustered by genotype may be due to increased transmission in winter with progression to 
disease diagnosed in spring. Further research, including correlation with other seasonally 
expressed diseases and the role of seasonal immunologic changes, may clarify specific 
factors leading to the seasonality of tuberculosis in the United States.
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Seasonal decomposition of laboratory-confirmed tuberculosis cases per month, United 
States, 1993–2008; raw data (A) with trend (B), seasonal factor (C), and irregular (random) 
factor (D).
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Table 1
Timing and Amplitude of Seasonality of Laboratory-Confirmed Tuberculosis Cases in the 
United States, 1993–2008
Characteristic No. of Cases Peak/Trough Month
Mean Seasonal Amplitude (95% 
CI)
All cases 243 432 March/November 21.4 (20.5–22.4)
Latitude North of 44.0°N 11 849 May/February 25.3 (23.0–27.5)
40°–43.9°N 47 567 May/December 26.4 (25.2–27.6)
36°–39.9°N 73 341 May/November 23.7 (21.8–25.5)
32°–35.9°N 40 490 March/November 28.6 (27.1–29.9)
South of 32°N 49 515 March/November 23.9 (22.4–25.2)
Age 0–4 y 7351 March/November 55.5 (49.2–61.7)
5–14 y 5391 March/November 37.1 (34.9–39.4)
15–24 y 23 643 March/November 33.8 (32.9–34.8)
25–44 y 88 039 March/November 23.5 (22.3–24.7)
45–64 y 67 401 June/November 22.5 (21.2–23.7)
≥65 y 51 576 June/November 19.4 (18.5–20.2)
Cluster statusa Clustered 6013 May/November 44.9 (44.1–45.6)
Nonclustered 21 593 Seasonality not detectedb
Race Black 75 957 March/November 29.2 (28.4–30.0)
Hispanic 58 474 May/November 26.9 (25.4–28.3)
Asian 49 785 April/November 23.8 (23.1–24.5)
White 53 763 May/November 17.8 (16.3–19.3)
Chest radiograph Cavitary 54 190 March/November 28.7 (27.8–29.6)
Noncavitary 139 717 March/November 21.2 (20.5–21.9)
Disease site Pulmonary only 179 106 March/November 21.0 (19.8–22.2)
Extrapulmonary only 45 094 May/November 32.2 (31.4–32.9)
HIV statusc Positive 21 894 May/November 27.3 (22.9–33.4)
Negative 92 769 March/November 28.7 (25.9–35.9)
Origin and years in the 
United States US born 132 216 March/November 24.3 (22.6–26.1)
Foreign born 91 481 March/November 22.2 (21.2–23.1)
Foreign born ≤1 year in the US 28 305 March/February 17.6 (15.5–19.6)
Foreign born >1 year in the US 63 176 May/December 26.1 (25.0–27.2)
Sex Male 152 552 March/November 23.6 (22.8–24.3)
Female 90 284 May/November 22.8 (22.4–23.4)
Abbreviations: CI, confidence interval; HIV, human immunodeficiency virus.
aCluster analysis is limited to 1 January 2005 through 30 November 2008; clustered cases were defined as cases with indistinguishable tuberculosis 
genotypes that were statistically significantly geospatially clustered.
bSeasonality not present according to the X-11 combined test of identifiable seasonality.





















Willis et al. Page 13
cCalifornia reported state AIDS-registry-matched tuberculosis patients as HIV positive through 2004; all other California tuberculosis patients are 
missing HIV status. Vermont has not reported HIV status since 2006.
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Table 2
Timing and Amplitude of Seasonality of Laboratory-Confirmed Tuberculosis Among 
Persons of Black Race in the United States, 1993–2008
Characteristic No. of Cases Peak/Trough Month
Mean Seasonal Amplitude (95% Confidence 
Interval)
All cases, black race 75 957 March/November 29.2 (28.4–30.0)
Latitude North of 40.0°Na 19 075 May/November 29.2 (27.5–30.9)
36°N–39.9°N 12 528 March/November 28.6 (25.0–32.2)
32°N–35.9°N 18 908 March/November 33.7 (32.8–34.5)
South of 32°N 17 243 May/November 31.3 (29.2–33.5)
Age 0–14 ya 4241 May/November 60.0 (51.5–68.4)
15–24 y 6621 May/November 49.9 (47.3–52.4)
25–44 y 31 241 March/November 30.1 (29.0–32.5)
45–64 y 22 669 June/November 28.7 (27.2–30-.2)
≥65 y 11 173 May/November 25.6 (22.6–28.5)
Site of disease Pulmonary only 55 368 May/November 24.7 (22.5–26.8)
Extrapulmonary only 13 605 May/November 34.2 (32.3–36.0)
Chest radiograph Cavitary 18 834 March/November 33.9 (32.8–35.1)
Noncavitary 45 629 March/November 27.1 (26.4–27.7)
a
Latitude strata north of 40°N and age <14 years were combined to yield sufficient numbers to perform time-series decomposition.
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